Bombay Medico Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-06-2024
- Paid Up Capital ₹ 0.10 M
as on 23-06-2024
- Company Age 53 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.17 M
as on 23-06-2024
- Revenue 28.56%
(FY 2020)
- Profit -5.06%
(FY 2020)
- Ebitda -153.77%
(FY 2020)
- Net Worth 5.08%
(FY 2020)
- Total Assets 26.01%
(FY 2020)
About Bombay Medico
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.17 M.
Dinesh Popat, Anil Popat, and Bhavna Popat serve as directors at the Company.
- CIN/LLPIN
U51397MH1971PTC015028
- Company No.
015028
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 1971
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bombay Medico?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Popat  | Director | 17-Sep-2015 | Current |
| Anil Popat | Director | 02-May-1998 | Current |
| Bhavna Popat | Director | 04-Mar-2014 | Current |
Financial Performance and Corporate Structure Insights of Bombay Medico.
Bombay Medico Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 28.56% increase. The company also saw a slight decrease in profitability, with a 5.06% decrease in profit. The company's net worth moved up by a moderate rise of 5.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bombay Medico?
In 2020, Bombay Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dalvi Hospital Pharmacy Private LimitedActive 20 years 9 monthsAnil Popat and Bhavna Popat are mutual person
- Krish Investments Private LimitedActive 19 years 4 months
Anil Popat and Bhavna Popat are mutual person
- Sweven Healthcare Private LimitedActive 5 years 6 months
Anil Popat and Bhavna Popat are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 02 Mar 1989 | ₹0.08 M | Open |
Union Bank Of India Creation Date: 16 Feb 1977 | ₹0.03 M | Open |
Union Bank Of India Creation Date: 15 Feb 1977 | ₹0.03 M | Open |
How Many Employees Work at Bombay Medico?
Unlock and access historical data on people associated with Bombay Medico, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bombay Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
